Verwaltungsgerichtliche Verfahren gegen das Bundesinstitut für Arzneimittel und Medizinprodukte seit 2021

This procedure is a written question addressed to the German government regarding legal actions taken in administrative courts against the Federal Institute for Drugs and Medical Devices (BfArM) since 2021. It seeks transparency on the number and nature of lawsuits filed against the agency's regulatory decisions. This affects the BfArM's administrative operations and may impact pharmaceutical companies and medical device manufacturers whose product approvals or regulatory requirements are being challenged in court.